Shares finished down ~45% on Friday following Q3 results. Despite several bright spots like a massive beat in specialty pharmacy and the successful launch of Nexus, the call led to a great deal of confusion regarding Florida contract timing and guidance. In addition, a growing accounts payable line and the…
STLN Update
Messy update & call, but multi-year story unchanged
